ELEOS THERAPEUTICS
Eleos Therapeutics is a biotechnology company that focuses on developing a cardio protector molecule. The company was founded in 2016 by Yaniv Dolev and is headquartered in Tel Aviv, Israel.
ELEOS THERAPEUTICS
Industry:
Biotechnology Medical Device
Founded:
2016-05-01
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
De Western Therapeutics Institute
De Western Therapeutics Institute is a biotechnology company that focuses on development of innovative new drags to serve patients worldwide
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Trishula Therapeutics
Trishula Therapeutics is a biotechnology company that focus on developing cancer medicines.
Current Employees Featured
Founder
More informations about "Eleos Therapeutics"
Eleos Therapeutics: Drug pipelines, Patents, Clinical trials - Synapse
Chicago-based private not-for-profit behavioral health care organization Trilogy is the first to deploy Eleos Outreach. The platform uses augmented intelligence to streamline the …See details»
Eleos, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Eleos, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, and 4 literature, Drug:Cenersen, P53 targeted cancer therapeutics (Eleos).See details»
P53 targeted cancer therapeutics (Eleos) - Drug Targets, …
P53 targeted cancer therapeutics (Eleos), Initially developed by Eleos, Inc., Now, its global highest R&D status is Pending, Therapeutic Areas: Neoplasms.See details»
Automation and AI Solutions for Healthcare | Eleos Health
Eleos Health provides AI-powered, highly compliant documentation automation to ease the operational burden on behavioral healthcare providers.See details»
Digital Therapeutics vs. Augmented Intelligence | Eleos …
Nov 7, 2024 Ready to take your organization into the future with purpose-built behavioral health AI? Request a demo of the Eleos platform here.See details»
The latest R&D info about Eleos Therapeutics: pipelines, patents ...
May 10, 2023 With Replay, organizations can enhance training and development programs, and gain additional insights into workforce needs and performance. About Eleos Health Eleos …See details»
Eleos Health 2025 Company Profile: Valuation, Funding …
Information on valuation, funding, cap tables, investors, and executives for Eleos Health. Use the PitchBook Platform to explore the full profile.See details»
Eleos Health - 2025 Company Profile - Tracxn
4 days ago Eleos Health - AI-based behavioral health diagnosis and management system for providers. Raised a total funding of $126M over 5 rounds from 17 investors.See details»
Eleos Health: Reducing the Workforce Burden on Mental Health
This allows Eleos to accurately interpret, analyze and document behavioral health conversations, thereby reducing the operational burden on providers while unlocking objective insights into …See details»
Eleos Therapeutics - Crunchbase
Eleos Therapeutics is a biotechnology company that focuses on developing a cardio protector molecule.See details»
Eleos Health Aims to Improve Addiction Therapy Outcomes
Oct 15, 2020 Eleos Health is a behavioral health technology firm attempting to position itself on the front edge of data-based AI therapeutics. The company’s artificial intelligence platform was …See details»
Eleos Therapeutics - Contacts, Employees, Board Members
Eleos Therapeutics is a biotechnology company that focuses on developing a cardio protector molecule.See details»
Eleos, Inc.: Drug pipelines, Patents, Clinical trials - Synapse
Explore Eleos, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 9 news, Drug:Cenersen, P53 targeted cancer therapeutics (Eleos).See details»
Eleos Raises $60M Series C to Transform Behavioral Health with AI ...
Jan 22, 2025 Eleos, the leader in AI for behavioral health, today announced a $60M Series C funding round led by Greenfield Partners, with participation from existSee details»
Behavioral health AI leader Eleos Health raises $40M Series B …
BOSTON and TEL AVIV, Israel, November 8, 2023-- Eleos Health, the leader in AI for behavioral health, today announced a $40M Series B funding round led by Menlo Ventures, with …See details»
Science of Augmented Intelligence in Healthcare | Eleos Health
Learn about the research supporting the use of pragmatic AI-augmentation in behavioral healthcare to optimize treatment and reduce the likelihood of provider burnout.See details»
Eleos secures $60M to support substance use disorder treatment …
Jan 22, 2025 Eleos, a behavioural health solutions startup offering AI agents designed to tackle administrative tasks for clinicians, announced that it secured $60 million in a series C, bringing …See details»
Eleos’ AI Agents Transforming Behavioral Health Raises $60M …
Jan 29, 2025 Eleos Health announced $60M in Series C funding supporting its AI Agents improving workflows for Behavioral Healthcare providers.See details»
Behavioral Health AI Leader Eleos Health Raises $40M Series B …
Dec 1, 2023 Eleos Health, the leader in AI for behavioral health, today announced a $40M Series B funding round led by Menlo Ventures, with participation from F-Prime Capital, Eight …See details»
New study results reinforce Tagrisso as the backbone therapy for …
5 days ago New study results presented at the European Lung Cancer Congress (ELCC) 2025, 26 to 29 March, demonstrate the role of AstraZeneca’s Tagrisso (osimertinib), as monotherapy …See details»